FYCOMPA

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, UK.

Active ingredients

The drug FYCOMPA contains one active pharmaceutical ingredient (API):

1	Perampanel UNII H821664NPK - PERAMPANEL
	Perampanel is a first-in-class selective, non-competitive antagonist of the ionotropic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) glutamate receptor on post-synaptic neurons. Glutamate is the primary excitatory neurotransmitter in the central nervous system and is implicated in a number of neurological disorders caused by neuronal overexcitation. The precise mechanism by which perampanel exerts its antiepileptic effects in humans remains to be fully elucidated.
	Read more about Perampanel

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FYCOMPA Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N03AX22	Perampanel	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AX Other antiepileptics
Discover more medicines within N03AX22

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10151G, 10157N, 10159Q, 10160R, 10162W, 10163X, 11407J, 11409L, 11418Y, 11428L, 11429M, 11436X
BR	Câmara de Regulação do Mercado de Medicamentos	533220060002917, 533220060003017, 533220060003117, 533220060003217, 533220060003317, 533220060003417
CA	Health Products and Food Branch	02404516, 02404524, 02404532, 02404540, 02404559, 02404567
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	5538-MEE-1020, 5545-MEE-1020, 5555-MEE-1020, 5561-MEE-1020
EE	Ravimiamet	1589902, 1589913, 1589924, 1589935, 1589946, 1589957, 1589968, 1589979, 1589980, 1589991, 1590005, 1590016, 1590027, 1590038, 1590049, 1590050, 1597877, 1597888, 1597901, 1597912, 1597923, 1597934, 1597945, 1729302
ES	Centro de información online de medicamentos de la AEMPS	112776024, 12776001, 12776003, 12776006, 12776009, 12776012, 12776015
FI	Lääkealan turvallisuus- ja kehittämiskeskus	064053, 169621, 375202, 432761, 475696, 506125, 560666
FR	Base de données publique des médicaments	61849146, 63602479, 64387360, 65931110, 68328199, 69856153
GB	Medicines & Healthcare Products Regulatory Agency	212122, 212128, 212131, 212134, 212137, 212140, 297739, 367771, 368022, 368024, 368026, 368028, 368030, 368032, 374383, 381368, 381370, 381372, 381374, 381376, 381378
HK	Department of Health Drug Office	62759, 62760, 62761, 62762, 62763, 62764
IE	Health Products Regulatory Authority	43760, 43761, 43762, 43763, 43764, 43765, 43783, 43784, 43785, 43786, 43787, 43788, 43790, 43792, 43973
IL	מִשְׂרַד הַבְּרִיאוּת	7262, 7263, 7264, 7265, 7266, 7267, 9340
JP	医薬品医療機器総合機構	1139014C1026, 1139014F1022, 1139014F2029
LT	Valstybinė vaistų kontrolės tarnyba	1067139, 1067140, 1067141, 1067142, 1067143, 1067144, 1067145, 1067146, 1067147, 1067148, 1067149, 1067150, 1067151, 1067152, 1067153, 1067154, 1068415, 1068416, 1068417, 1068418, 1068419, 1068420, 1068421, 1081755
NL	Z-Index G-Standaard, PRK	115460, 115479, 115487, 115495, 115509, 115517, 197084
NZ	Medicines and Medical Devices Safety Authority	21106, 21107, 21108, 21109, 21110, 21111, 22305
PL	Rejestru Produktów Leczniczych	100309786, 100309792, 100309800, 100309817, 100309823, 100309830, 100383268
SG	Health Sciences Authority	14616P, 14617P, 14618P, 14619P, 14620P, 14621P
US	FDA, National Drug Code	62856-272, 62856-274, 62856-276, 62856-278, 62856-280, 62856-282, 62856-290
ZA	Health Products Regulatory Authority	47/2.5/1196, 47/2.5/1197, 47/2.5/1198, 47/2.5/1199, 47/2.5/1200, 47/2.5/1201